Morgan Stanley Believes the Long-Term Thesis on Aetna is Intact
February 07, 2014 at 09:28 AM EST
In a report published Friday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating and $83.00 price target on Aetna (NYSE: AET ). In the report, Morgan Stanley noted, “AET maintained its adjusted EPS guidance of ‘at least $6.25' for FY14 after reporting $6.25 for FY13. We continue to view